ErVac-01

N/A

Report date: 2026/02/27 20:01:47

Base Information

Drug NameErVac-01
Drug Alias NameErVac-01ErVac01
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErVimmune SAS
China Registration ClassN/A

Develop Information

Active CompaniesErVimmune SAS
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A